The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
The Prescribing Medicines in Pregnancy database has now been updated to include the following new entries:
- amifampridine - pregnancy category C
- amphotericin B (liposomal) - pregnancy category B2
- alpelisib - pregnancy category D
- avalglucosidase alfa - pregnancy category B1
- axicabtagene ciloleucel - pregnancy category C
- burosumab - pregnancy category B3
- brexucabtagene autoleucel - pregnancy category C
- casirivimab / imdevimab - pregnancy category B2
- COVID-19 Vaccine - elasomeran - pregnancy category B1
- COVID-19 Vaccine - SARS-CoV-2 rS (NVX-CoV2373) - pregnancy category B1
- esketamine - pregnancy category B3
- fibrinogen / thrombin - pregnancy category B2
- finerenone - pregnancy category D
- inclisiran - pregnancy category B1
- infigratinib - pregnancy category D
- lemborexant - pregnancy category B3
- lurbinectedin - pregnancy category D
- lutetium (177Lu) chloride - pregnancy category X
- molnupiravir - pregnancy category D
- nirmatrelvir - pregnancy category B3
- pegvaliase - pregnancy category D
- regdanvimab - pregnancy category B2
- sacituzumab govitecan - pregnancy category D
- sotrovimab - pregnancy category B2
- ticagrelor - pregnancy category B1
- tisagenlecleucel - pregnancy category C
- vericiguat - pregnancy category D
- vortioxetine - pregnancy category B3
- zanubrutinib - pregnancy category D
The following entries have been amended:
- carbimazole - pregnancy category from C to D
- propylthiouracil - pregnancy category from C to D
- COVID-19 Vaccine - BNT162b2 (mRNA) - change of name: COVID-19 vaccine - tozinameran